Clearside Biomedical, Inc. Added to NASDAQ Biotechnology Index
December 14, 2016 16:15 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Dec. 14, 2016 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat...
Clearside Biomedical, Inc. Announces Pricing of Public Offering of Common Stock
December 09, 2016 09:20 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat...
Clearside Biomedical, Inc. Announces Proposed Offering of Common Stock
December 07, 2016 16:02 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Dec. 07, 2016 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat...
Clearside Biomedical, Inc. Announces Third Quarter 2016 Financial Results and Provides Corporate Update
November 09, 2016 07:00 ET
|
Clearside Biomedical, Inc.
Phase 3 Program of Zuprata™ for Macular Edema Associated with Retinal Vein Occlusion to be Initiated in the First Half of 2017 Phase 1/2 Trial for Diabetic Macular Edema to be Initiated by the End...
Clearside Biomedical, Inc. to Present at the 2016 Stifel Healthcare Conference on Wednesday, November 16, 2016
November 08, 2016 16:30 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat...
Clearside Biomedical, Inc. Names Rick McElheny as Vice President, Business Development
November 08, 2016 07:00 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat...
Clearside Biomedical, Inc. to Report Third Quarter 2016 Financial Results and Host Conference Call on Wednesday, November 9, 2016
November 02, 2016 07:00 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat...
Clearside Biomedical, Inc. Announces Pricing of Initial Public Offering
June 01, 2016 23:15 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., June 01, 2016 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat...